{
  "ticker": "KZR",
  "company_name": "Kezar Life Sciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05047536",
      "title": "KZR-261 in Subjects With Advanced Solid Malignancies",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Advanced/Metastatic Solid Tumor",
      "start_date": "2021-09-30",
      "completion_date": "2025-01-17",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT05569759",
      "title": "A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Autoimmune Hepatitis",
      "start_date": "2023-05-23",
      "completion_date": "2025-04-30",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT04033926",
      "title": "A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Polymyositis, Dermatomyositis",
      "start_date": "2020-01-14",
      "completion_date": "2022-04-06",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT04039477",
      "title": "A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Autoimmune Hemolytic Anemia, Immune Thrombocytopenia",
      "start_date": "2020-07",
      "completion_date": "2020-08-05",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT03393013",
      "title": "A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Lupus Nephritis, Systemic Lupus Erythematosus",
      "start_date": "2018-02-20",
      "completion_date": "2022-08-04",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT05781750",
      "title": "A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Lupus Nephritis",
      "start_date": "2023-11-03",
      "completion_date": "2024-11-08",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    },
    {
      "nct_id": "NCT04628936",
      "title": "Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Polymyositis, Dermatomyositis",
      "start_date": "2020-11-04",
      "completion_date": "2023-06-12",
      "enrollment": 0,
      "sponsor": "Kezar Life Sciences, Inc."
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 1,
      "PHASE2": 5,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "TERMINATED": 2,
      "COMPLETED": 4,
      "WITHDRAWN": 1
    },
    "active_trials": 0,
    "completed_trials": 4,
    "conditions": [
      "Advanced/Metastatic Solid Tumor",
      "Autoimmune Hemolytic Anemia, Immune Thrombocytopenia",
      "Autoimmune Hepatitis",
      "Lupus Nephritis",
      "Lupus Nephritis, Systemic Lupus Erythematosus",
      "Polymyositis, Dermatomyositis"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T13:12:15.508137",
    "search_query": "Kezar Life Sciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Kezar+Life+Sciences,+Inc."
  }
}